Dr. Ricardo Loret de Mola and Dr. Kanako Hayashi were honored with the award for the best poster at the 4 th European Congress on Endometriosis in Vienna, Austria. The poster entitled “Suppression of inflammatory responses in endometrial lesions by reducing the secretion of cytokines and chemokines” is the result of a collaborative effort between Dr. Loret de Mola a clinical expert in the field of reproductive endocrinology with a special interest in endometriosis and Dr. Hayashi, a discovery science researcher at the SIU Carbondale campus who has years of experience studying female

DUE DATE: Fall cycle-November 30th / Spring cycle-May 31st If the above dates fall on the weekend or a holiday, applications will be due the next business day. The goal of the Near-Miss funding program is to support the improvement of grant applications submitted for Federal type funding but were not funded. These applications are reviewed by an ad hoc review committee appointed by the ADR. I. Eligibility highlights SIUSM faculty member must be at the instructor/lecturer level (including Research or Clinical Assistant Professor) or above. Volunteer faculty members are not eligible. An

SIU School of Medicine authors published 22 articles in the past month that were added to PubMed. Display the 22 citations in PubMed

Alzheimer’s is a devastatingly progressive disease that robs our loved ones of their memories and personalities. Presently 5.7 million Americans are living with Alzheimer’s. By 2050, this number is projected to rise to nearly 14 million. Early and accurate diagnosis could save up to $7.9 trillion in medical and care costs, according to the Alzheimer’s Association. There is increasing evidence that Alzheimer’s disease lies on a continuum with dynamic neurobiological and pathological symptoms. As the disease progresses, targeting specific therapeutic windows for intervention may give patients

Alzheimer’s is a devastatingly progressive disease that robs our loved ones of their memories and personalities. Presently 5.7 million Americans are living with Alzheimer’s. By 2050, this number is projected to rise to nearly 14 million. Early and accurate diagnosis could save up to $7.9 trillion in medical and care costs, according to the Alzheimer’s Association. There is increasing evidence that Alzheimer’s disease lies on a continuum with dynamic neurobiological and pathological symptoms. As the disease progresses, targeting specific therapeutic windows for intervention may give patients

Southern Illinois University School of Medicine (Springfield) relies on the Collaborative Institutional Training Initiative Program (CITI) to fulfill Financial Conflict of Interest (FCOI) Training required for all personnel involved in federally funded research. Successful completion of Financial Conflict of Interest training is required before research personnel can engage in research activities. Once successfully completed, the training is good for four years. Automated renewal notices will alert you to when you must renew your training. New employees must register and complete the CITI FCOI

All applications for external funding, letters of intent including budget information, and subcontracts/consortia submitted from SIU School of Medicine must be reviewed and approved before submission through the Associate Dean for Research Office. To allow sufficient time for application review and approval. Please send an initial notification of intent to apply for any mechanism and the funding agency guidelines as far in advance as possible, at the very least, 2 weeks before the submission deadline. Forms due to the Grants Office by 8 a.m., 3 weeks before the submission deadline: Application

Dana Suskind is co-director of the TMW Center for Early Learning + Public Health at the University of Chicago. A professor of surgery, she is founder and director of the Pediatric Cochlear Implant Program, and founder and director of Thirty Million Words. She received her MD at the University of Missouri-Kansas City School of Medicine. She completed her residency in otorhinolaryngology, specializing in head and neck surgery, at the Hospital of the University of Pennsylvania, and fellowship in pediatric otolaryngology at the Children’s Hospital at the Washington University School of Medicine in

Paul Bloom is Vice President, Process and Chemical Research, at Archer Daniels Midland Company. In that role, he leads research efforts in process development and chemical research to help ADM develop technologies that will improve the company’s cost position and drive new product opportunities. He also works with ADM’s commercial and production teams to move technologies from the laboratory to deployment. Bloom joined ADM in 2001 as a research scientist and, in 2007, was named director, Chemical Technology Strategy; during his time at ADM, he has authored more than 20 patents. He also played

Linda Reneé Baker joined the Paul Simon Public Policy Institute on March 18, 2003, after stepping down as the secretary of Illinois Department of Human Services, a post she held for three years. Her focus at the institute is to expand access to high-quality health care in partnership with the SIU School of Medicine and helping minorities and people with disabilities realize their full potential. She also teaches a course on leadership for SIU Carbondale. During her career in public service, Baker held increasingly responsible positions in a variety of state agencies. As secretary of the